Compound Detail
CHEMBL1241127
SALICYLALDOXIME Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1241127 |
| Name | SALICYLALDOXIME |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RFUHYBGHIJSEHB-VGOFMYFVSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
245.2
MW (Da)
2.28
ALogP
5
HBA
4
HBD
93.3
PSA (Ų)
0.37
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.72
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MDA-MB-231 CHEMBL400 | IC50 | 4.72 | 4.72 | 19200.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MDA-MB-231 | IC50 | = | 19200.0 | nM | 4.72 | Antitumor activity against human MDA-MB-231 cells after 6 days by SRB assay | 20728369 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 20728369 | 10.1016/j.bmc.2010.07.059 | Aorta | 3 |
| 20728369 | 10.1016/j.bmc.2010.07.059 | MDA-MB-231 | 1 |
Data from ChEMBL 36 via Core Engine